Nan Fung Trinity (Hk) LTD Alx Oncology Holdings Inc Transaction History
Nan Fung Trinity (Hk) LTD
- $811 Million
- Q2 2025
A detailed history of Nan Fung Trinity (Hk) LTD transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Nan Fung Trinity (Hk) LTD holds 41,950 shares of ALXO stock, worth $68,798. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,950Holding current value
$68,798% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALXO
# of Institutions
67Shares Held
31.6MCall Options Held
53.8KPut Options Held
11.7K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$15.9 Million4.29% of portfolio
-
Redmile Group, LLC San Francisco, CA3.39MShares$5.56 Million0.17% of portfolio
-
Tang Capital Management LLC San Diego, CA3.16MShares$5.18 Million0.08% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$4.41 Million0.0% of portfolio
-
Almitas Capital LLC Santa Monica, CA2.54MShares$4.16 Million0.5% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $66.8M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...